Literature DB >> 35681094

Neurological implications of antenatal corticosteroids on late preterm and term infants: a scoping review.

Emily B Sarid1, Michelle L Stoopler1, Anne-Maude Morency2, Jarred Garfinkle3.   

Abstract

The objective of this study was to synthesize the body of knowledge on the association between ACS exposure for risk of preterm birth and brain development in infants ultimately born late preterm and term. Three databases and eight conference proceedings were systematically searched (1972-2021). Selection criteria included ACS administration for risk of preterm delivery, cohort of late preterm and term infants, and assessment of brain development. Data on study characteristics, ACS administration, and neurological outcomes were extracted and qualitatively synthesized according to themes. Neurological outcomes of the included studies (n = 27) were grouped into four themes. The most common adverse outcomes were reduced neonatal head circumference, structural cortical differences on MRI, increased prevalence of psychiatric problems, and increased risk of neurodevelopmental delays in ACS-exposed late preterm and term infants. Our scoping review demonstrated that ACS exposure for risk of preterm delivery may have important neurological implications in infants ultimately born late preterm and term. Given that the existing research is at serious risk for bias, further research that accounts for confounders such as preterm labor, maternal stress, and the number of ACS courses is needed to better establish the long-term neurological effects of ACS on late preterm and term infants. IMPACT: Due to the difficulty in predicting preterm birth, approximately 40% of fetuses exposed to antenatal corticosteroids (ACS) are born at term (≥37 weeks' gestation). This scoping review summarizes the knowledge on the association between ACS exposure for risk of preterm birth and brain development in late preterm and term infants. The majority of studies reported that ACS exposure was associated with adverse brain development outcomes across various domains, such as reduced neonatal head circumference, cortical differences on MRI, and increased prevalence of psychiatric problems and neurodevelopmental delays in late preterm and term infants.
© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Year:  2022        PMID: 35681094     DOI: 10.1038/s41390-022-02135-3

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  32 in total

1.  Prenatal dexamethasone exposure affects anxiety-like behaviour and neuroendocrine systems in an age-dependent manner.

Authors:  Masatoshi Nagano; Hitoshi Ozawa; Hidenori Suzuki
Journal:  Neurosci Res       Date:  2007-12-23       Impact factor: 3.304

2.  Glucocorticoid exposure during hippocampal neurogenesis primes future stress response by inducing changes in DNA methylation.

Authors:  Nadine Provençal; Janine Arloth; Annamaria Cattaneo; Christoph Anacker; Nadia Cattane; Tobias Wiechmann; Simone Röh; Maik Ködel; Torsten Klengel; Darina Czamara; Nikola S Müller; Jari Lahti; Katri Räikkönen; Carmine M Pariante; Elisabeth B Binder
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-09       Impact factor: 11.205

3.  No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes.

Authors:  Amanda Skoll; Amélie Boutin; Emmanuel Bujold; Jason Burrows; Joan Crane; Michael Geary; Venu Jain; Thierry Lacaze-Masmonteil; Jessica Liauw; William Mundle; Kellie Murphy; Suzanne Wong; K S Joseph
Journal:  J Obstet Gynaecol Can       Date:  2018-09

4.  Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial.

Authors:  Stuart R Dalziel; Vanessa K Lim; Anthony Lambert; Dianne McCarthy; Varsha Parag; Anthony Rodgers; Jane E Harding
Journal:  BMJ       Date:  2005-09-05

5.  Long-term neuropathological and/or neurobehavioral effects of antenatal corticosteroid therapy in animal models: a systematic review.

Authors:  Johannes L van der Merwe; Adalina Sacco; Jaan Toelen; Jan Deprest
Journal:  Pediatr Res       Date:  2019-12-10       Impact factor: 3.756

6.  Induction of a hyperanxious state by antenatal dexamethasone: a case for less detrimental natural corticosteroids.

Authors:  Mário Oliveira; João M Bessa; Ana Mesquita; Hugo Tavares; André Carvalho; Rui Silva; José M Pêgo; João J Cerqueira; Joana A Palha; Osborne F X Almeida; Nuno Sousa
Journal:  Biol Psychiatry       Date:  2005-09-28       Impact factor: 13.382

7.  A placebo-controlled comparison between betamethasone and dexamethasone for fetal maturation: differences in neurobehavioral development of mice offspring.

Authors:  W F Rayburn; H D Christensen; C L Gonzalez
Journal:  Am J Obstet Gynecol       Date:  1997-04       Impact factor: 8.661

8.  Prenatal betamethasone exposure and psychopathology risk in extremely low birth weight survivors in the third and fourth decades of life.

Authors:  Calan Savoy; Mark A Ferro; Louis A Schmidt; Saroj Saigal; Ryan J Van Lieshout
Journal:  Psychoneuroendocrinology       Date:  2016-09-28       Impact factor: 4.905

9.  Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice.

Authors:  R Gandelman; C Rosenthal
Journal:  Teratology       Date:  1981-12

Review 10.  Neurotoxicity of glucocorticoids in the primate brain.

Authors:  H Uno; S Eisele; A Sakai; S Shelton; E Baker; O DeJesus; J Holden
Journal:  Horm Behav       Date:  1994-12       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.